StonvexLoading…
StonvexStonvexStonvexCore line items from SYM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-27 | Annual 2024 2024-09-28 | Annual 2024 2024-06-29 | Annual 2024 2024-03-30 |
|---|---|---|---|---|
Revenue | $2.25B | $1.79B | $470.34M | $393.33M |
Operating Income | $-115.01M | $-116.72M | $-37.62M | $-64.89M |
Net Income | $-16.94M | $-13.49M | $-4.68M | $-8.81M |
EPS (Diluted) | $-0.16 | $-0.14 | $-0.05 | $-0.09 |
Total Assets | $2.40B | $1.58B | Not available | Not available |
Total Liabilities | $1.92B | $1.19B | Not available | Not available |
Cash & Equivalents | $1.24B | $727.31M | Not available | Not available |
Free Cash Flow OCF − CapEx | Not available | $-100.31M | Not available | Not available |
Shares Outstanding | 590.89M | 585.96M | Not available | Not available |